Healthcare players in Japan are expected to adjust FY25 guidance due to exchange rate appreciation, requiring investors to be cautious in their selections, focusing on fundamental business strength.
What is covered in the Full Insight:
Introduction
Impact of BoJ Interest Rate Hike
Healthcare Companies' Performance in Q1FY25
Future Outlook for Japanese Healthcare Sector
Conclusion
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.